543998 Stock Overview
Operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Valiant Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹112.90 |
| 52 Week High | ₹226.95 |
| 52 Week Low | ₹99.90 |
| Beta | 0 |
| 11 Month Change | 5.27% |
| 3 Month Change | -1.22% |
| 1 Year Change | -38.77% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -33.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543998 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.3% | 0.5% | 0.5% |
| 1Y | -38.8% | 42.5% | 27.5% |
Return vs Industry: 543998 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 543998 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 543998 volatility | |
|---|---|
| 543998 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 543998 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543998's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 77 | Santosh Vora | valiantlabs.in |
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals.
Valiant Laboratories Limited Fundamentals Summary
| 543998 fundamental statistics | |
|---|---|
| Market cap | ₹4.82b |
| Earnings (TTM) | -₹99.92m |
| Revenue (TTM) | ₹1.11b |
4.4x
P/S Ratio-49.1x
P/E RatioIs 543998 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543998 income statement (TTM) | |
|---|---|
| Revenue | ₹1.11b |
| Cost of Revenue | ₹1.13b |
| Gross Profit | -₹14.87m |
| Other Expenses | ₹85.05m |
| Earnings | -₹99.92m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.30 |
| Gross Margin | -1.33% |
| Net Profit Margin | -8.96% |
| Debt/Equity Ratio | 49.7% |
How did 543998 perform over the long term?
See historical performance and comparison